BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 11965174)

  • 1. [Subjective blockage in Parkinson's disease].
    Volpe-Gillot L; Créange A; Degos JD
    Rev Neurol (Paris); 2002 Feb; 158(2):185-93. PubMed ID: 11965174
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Depression in Parkinson's disease and its relation to the cognitive and motor manifestations].
    Gil Saladié D; Delgado González M; Oliveras Ley C; Peña Casanova J; Barraquer Bordas L
    Neurologia; 1992; 7(7):176-80. PubMed ID: 1419086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Parkinson's disease progression at 30 years: a study of subthalamic deep brain-stimulated patients.
    Merola A; Zibetti M; Angrisano S; Rizzi L; Ricchi V; Artusi CA; Lanotte M; Rizzone MG; Lopiano L
    Brain; 2011 Jul; 134(Pt 7):2074-84. PubMed ID: 21666262
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Non-motor dopamine withdrawal syndrome after surgery for Parkinson's disease: predictors and underlying mesolimbic denervation.
    Thobois S; Ardouin C; Lhommée E; Klinger H; Lagrange C; Xie J; Fraix V; Coelho Braga MC; Hassani R; Kistner A; Juphard A; Seigneuret E; Chabardes S; Mertens P; Polo G; Reilhac A; Costes N; LeBars D; Savasta M; Tremblay L; Quesada JL; Bosson JL; Benabid AL; Broussolle E; Pollak P; Krack P
    Brain; 2010 Apr; 133(Pt 4):1111-27. PubMed ID: 20237128
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Motor and cognitive outcome in patients with Parkinson's disease 8 years after subthalamic implants.
    Fasano A; Romito LM; Daniele A; Piano C; Zinno M; Bentivoglio AR; Albanese A
    Brain; 2010 Sep; 133(9):2664-76. PubMed ID: 20802207
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Impact of non-motor symptoms on health-related and perceived quality of life in Parkinson's disease.
    Santos-García D; de la Fuente-Fernández R
    J Neurol Sci; 2013 Sep; 332(1-2):136-40. PubMed ID: 23890935
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Management of psychiatric complications of Parkinson's disease].
    Fénelon G
    Rev Prat; 2005 Apr; 55(7):733-9. PubMed ID: 15966416
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Psychoses in patients with Parkinson's disease; their frequency, phenomenology, and clinical correlates].
    Kashihara K; Ohno M; Katsu Y
    Rinsho Shinkeigaku; 2005 Jan; 45(1):1-5. PubMed ID: 15714992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Five-year follow-up of bilateral stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Krack P; Batir A; Van Blercom N; Chabardes S; Fraix V; Ardouin C; Koudsie A; Limousin PD; Benazzouz A; LeBas JF; Benabid AL; Pollak P
    N Engl J Med; 2003 Nov; 349(20):1925-34. PubMed ID: 14614167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Subthalamic stimulation in Parkinson's disease: restoring the balance of motivated behaviours.
    Lhommée E; Klinger H; Thobois S; Schmitt E; Ardouin C; Bichon A; Kistner A; Fraix V; Xie J; Aya Kombo M; Chabardès S; Seigneuret E; Benabid AL; Mertens P; Polo G; Carnicella S; Quesada JL; Bosson JL; Broussolle E; Pollak P; Krack P
    Brain; 2012 May; 135(Pt 5):1463-77. PubMed ID: 22508959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gender differences in motor and non-motor symptoms among Sardinian patients with Parkinson's disease.
    Solla P; Cannas A; Ibba FC; Loi F; Corona M; Orofino G; Marrosu MG; Marrosu F
    J Neurol Sci; 2012 Dec; 323(1-2):33-9. PubMed ID: 22935408
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Improvements in motor and non-motor symptoms in parkinson patients under ropinirole therapy].
    Buchwald B; Angersbach D; Jost WH
    Fortschr Neurol Psychiatr; 2007 Apr; 75(4):236-41. PubMed ID: 17427044
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of non-motor symptoms in advanced Parkinson disease.
    Truong DD; Bhidayasiri R; Wolters E
    J Neurol Sci; 2008 Mar; 266(1-2):216-28. PubMed ID: 17804018
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Electrical stimulation of the subthalamic nucleus in advanced Parkinson's disease.
    Limousin P; Krack P; Pollak P; Benazzouz A; Ardouin C; Hoffmann D; Benabid AL
    N Engl J Med; 1998 Oct; 339(16):1105-11. PubMed ID: 9770557
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acute psychotropic effects of bilateral subthalamic nucleus stimulation and levodopa in Parkinson's disease.
    Funkiewiez A; Ardouin C; Krack P; Fraix V; Van Blercom N; Xie J; Moro E; Benabid AL; Pollak P
    Mov Disord; 2003 May; 18(5):524-30. PubMed ID: 12722166
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Parkinson's disease: psychological and behavioral disorders].
    Delgadillo-Iniguez D; Corvol JC; Gély-Nargeot MC; Lacomblez L
    Psychol Neuropsychiatr Vieil; 2006 Dec; 4 Spec No 1():S11-6. PubMed ID: 23631043
    [TBL] [Abstract][Full Text] [Related]  

  • 17. "DASH" symptoms in patients with Parkinson's disease: red flags for early cognitive decline.
    Naismith SL; Lewis SJ
    J Clin Neurosci; 2011 Mar; 18(3):352-5. PubMed ID: 21237647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Absence of cognitive deficits following deep brain stimulation of the subthalamic nucleus for the treatment of Parkinson's disease.
    Fraraccio M; Ptito A; Sadikot A; Panisset M; Dagher A
    Arch Clin Neuropsychol; 2008 Jul; 23(4):399-408. PubMed ID: 18394859
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bilateral subthalamic nucleus stimulation for Parkinson's disease.
    Doshi PK; Chhaya NA; Bhatt MA
    Neurol India; 2003 Mar; 51(1):43-8. PubMed ID: 12865514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Relationship between cognitive dysfunction and behavioural symptoms in Nigerian patients with Parkinson's disease no dementia.
    Ojagbemi A
    J Parkinsons Dis; 2013 Jan; 3(3):293-300. PubMed ID: 23963316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.